Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
0(0%)
Results Posted
40%(4 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_1
9
82%
Ph phase_2
2
18%

Phase Distribution

9

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
9(81.8%)
Phase 2Efficacy & side effects
2(18.2%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(10)
Terminated(1)

Detailed Status

Completed10
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
90.9%
Most Advanced
Phase 2

Trials by Phase

Phase 19 (81.8%)
Phase 22 (18.2%)

Trials by Status

completed1091%
terminated19%

Recent Activity

Clinical Trials (11)

Showing 11 of 11 trials
NCT02499328Phase 1

Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck

Completed
NCT03177187Phase 1

Combination Study of AZD5069 and Enzalutamide.

Terminated
NCT01704495Phase 2

A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.

Completed
NCT01890148Phase 1

Distribution of Neutrophils in Bronchial Mucosal Tissue in Asthma Patients Before and After 4 Weeks Treatment With AZD 5069

Completed
NCT01255592Phase 2

Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis

Completed
NCT01735240Phase 1

Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally.

Completed
NCT01051505Phase 1

A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Ascending Doses of AZD5069 in Healthy Volunteers

Completed
NCT01100047Phase 1

Japanese Single and Multiple Ascending Dose (JSMAD), Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of AZD5069

Completed
NCT01083238Phase 1

This Study Will Investigate How Food and Age Effect the Way the Body Handles the AZD5069 Drug Given as a Oral Dose

Completed
NCT00953888Phase 1

Study to Investigate the Safety, Tolerability and Activity of AZD5069 When Given as a Single Dose to Healthy Male and/or Female Subjects

Completed
NCT01962935Phase 1

Study to Investigate Safety, Tolerability and Effect of Multiple Dosing With AZD 4721 and/or With AZD 5069

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11